309.80
前日終値:
$300.25
開ける:
$303.18
24時間の取引高:
877.41K
Relative Volume:
0.65
時価総額:
$59.14B
収益:
$328.68B
当期純損益:
$2.55B
株価収益率:
23.77
EPS:
13.0349
ネットキャッシュフロー:
$1.56B
1週間 パフォーマンス:
-0.04%
1か月 パフォーマンス:
-6.41%
6か月 パフォーマンス:
-2.49%
1年 パフォーマンス:
-0.65%
Cencora Inc Stock (COR) Company Profile
Compare COR vs MCK, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
COR
Cencora Inc
|
309.90 | 58.57B | 328.68B | 2.55B | 1.56B | 13.03 |
|
MCK
Mckesson Corp
|
892.12 | 101.04B | 403.43B | 5.10B | 5.41B | 38.47 |
|
CAH
Cardinal Health Inc
|
229.39 | 50.99B | 250.74B | 1.55B | 4.39B | 6.5398 |
|
HSIC
Henry Schein Inc
|
84.87 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
|
AHG
Akso Health Group Adr
|
0.9998 | 642.53M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | アップグレード | Jefferies | Hold → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-09-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Equal Weight |
| 2023-03-31 | 開始されました | Citigroup | Buy |
| 2023-01-31 | 再開されました | Evercore ISI | Outperform |
| 2022-10-11 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-08-22 | 再開されました | Morgan Stanley | Equal-Weight |
| 2022-07-11 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-06-07 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-05-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-04-12 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | 再開されました | Evercore ISI | In-line |
| 2021-02-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-02-02 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-01-06 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-01-06 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 開始されました | Mizuho | Neutral |
| 2020-08-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 開始されました | Barclays | Underweight |
| 2020-06-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 再開されました | Credit Suisse | Outperform |
| 2020-04-16 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-03-17 | アップグレード | Citigroup | Neutral → Buy |
| 2020-02-11 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-07-10 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 開始されました | Guggenheim | Buy |
| 2019-04-10 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-02-11 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-10 | ダウングレード | Jefferies | Buy → Hold |
| 2018-10-26 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 開始されました | Berenberg | Buy |
| 2018-07-17 | 再開されました | Stifel | Hold |
| 2018-04-09 | 開始されました | MoffettNathanson | Buy |
| 2018-03-12 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 開始されました | JP Morgan | Neutral |
| 2017-09-22 | 開始されました | William Blair | Outperform |
すべてを表示
Cencora Inc (COR) 最新ニュース
Cencora Inc Lobbyists, 2014 - OpenSecrets
Cencora Inc Agencies, 2024 - OpenSecrets
Form 8K Cencora Inc For: 25 September By Investing.com - Investing.com Nigeria
Cencora Elects Former Ryder CEO Robert Sanchez to Board - citybiz
Cencora appoints former Ryder CEO to board of directors By Investing.com - Investing.com India
Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026 - marketscreener.com
Robert E. Sanchez appointed to Cencora board effective Oct 1, 2026 - TradingView
Cencora Elects Robert E. Sanchez to Its Board of Directors - marketscreener.com
Cencora (COR) Stock Forecast and Price Target 2026 $COR - MarketBeat
Cencora stock heads into the open after closing flat - AD HOC NEWS
Cencora (COR) Conference Updates Keep Undervalued Case In Focus - simplywall.st
Cencora stock trades at USD 314.64 below its yearly high - AD HOC NEWS
Cencora stock holds near USD 316 after strong quarterly results - AD HOC NEWS
Cencora stock holds at USD 308.78 as specialty growth supports outlook - AD HOC NEWS
Cencora stock heads into the open after a 1.5 percent market-led gain - AD HOC NEWS
Cencora stock gains as specialty strategy supports fiscal 2027 outlook - AD HOC NEWS
Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027 - Yahoo Finance
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference - Yahoo Finance
Cencora, Inc. (COR) Stock Analysis: Unveiling a 19.6% Potential Upside in the Healthcare Distribution Sector - DirectorsTalk Interviews
Cencora (COR) Lifts EPS Outlook And Buyback, Is The Stock Still Below Fair Value? - Yahoo Finance
Cencora Inc. stock gains after raising full-year EPS guidance - AD HOC NEWS
Cencora (COR) Raised Guidance and Bought Back $1B. What’s the Catch? - Yahoo Finance
What Makes the Latest Cencora (COR) Story Different? - kalkinemedia.com
Cencora Inc. stock eases after insider sale while earnings grow - AD HOC NEWS
Cencora Inc. stock eases after recent insider share sale - AD HOC NEWS
Cencora, Inc. (COR) Stock Forecasts - Yahoo Finance
Cencora (NYSE: COR) director sells $411K in shares - Stock Titan
Cencora Inc. stock gains after beating quarterly earnings estimates - AD HOC NEWS
Cencora Inc Hired Firms, 2026 - OpenSecrets
Cencora (NYSE: COR) director files notice for potential stock sale via Merrill Lynch - Stock Titan
Cencora, Inc. (COR) Stock Analysis: Strong Buy Ratings And A 14.85% Upside Potential - DirectorsTalk Interviews
$1000 Invested In Cencora 10 Years Ago Would Be Worth This Much Today - Benzinga
Cencora (COR) ex-officer lines up new stock sale - Stock Titan
Cencora stock heads into the open after a 0.1% dip - ad-hoc-news.de
Is Cencora (COR) Still Undervalued On Higher 2026 Guidance And Strong Q3 Earnings? - Yahoo Finance
Cencora Inc. stock dips after RBC reiterates cautious price target - ad-hoc-news.de
Is Cencora Stock Underperforming the Dow? - Yahoo Finance
Cencora stock price target maintained at $330 by RBC Capital By Investing.com - Investing.com Australia
Cencora stock heads into the open after a modest decline - ad-hoc-news.de
Cencora stock holds firm after RBC keeps $330 target - ad-hoc-news.de
Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Cencora stock price target maintained at $330 by RBC Capital - Investing.com Canada
Cencora's MWI Animal Health Merger With Covetrus Sees 'Intensified' FTC Scrutiny, RBC Says - Yahoo Finance
Cencora, Inc. (COR) Stock Analysis: Robust Growth in Medical Distribution with an 11.59% Upside Potential - DirectorsTalk Interviews
Cencora Inc. stock gains on solid fiscal 2026 momentum - ad-hoc-news.de
Why Cencora (COR) Is Getting Attention Today - simplywall.st
Cencora’s New Cell and Gene Services Might Change The Case For Investing In Cencora (COR) - simplywall.st
Cencora Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - Yahoo Finance
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Cencora Inc (COR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):